scholarly journals Prevalence of gingival enlargement secondary to calcium channel blockers in patients with cardiovascular diseases - (Retracted)

2012 ◽  
Vol 16 (3) ◽  
pp. 430 ◽  
Author(s):  
Priya Pedaballi ◽  
Rajasekar Sundaram ◽  
Mythili Ramachandran
Keyword(s):  
Cardiovascular Diseases ◽  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Channel Blockers ◽  
Gingival Enlargement

scholarly journals Gingival enlargement induced by dihydropyridine calcium channel blockers in a young child

2014 ◽  
Vol 2014 (sep08 1) ◽  
pp. bcr2014206761-bcr2014206761
Author(s):  
J. Miranda-Rius ◽  
L. Brunet-Llobet ◽  
E. Lahor-Soler ◽  
A. Ramirez-Ramiz
Keyword(s):  
Young Child ◽  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Channel Blockers ◽  
Gingival Enlargement

scholarly journals Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers

Marine Drugs ◽  
2018 ◽  
Vol 16 (12) ◽  
pp. 475 ◽  
Author(s):  
Dan Wang ◽  
Pratik Neupane ◽  
Lotten Ragnarsson ◽  
Robert Capon ◽  
Richard Lewis
Keyword(s):  
Cardiovascular Diseases ◽  
Patch Clamp ◽  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Absence Epilepsy ◽  
Channel Blockers ◽  
Synthetic Route ◽  
State Dependent ◽  
Whole Cell Patch Clamp ◽  
Potential Therapeutics

T-type calcium channel (CaV3.x) blockers are receiving increasing attention as potential therapeutics for the treatment of pathophysiological disorders and diseases, including absence epilepsy, Parkinson’s disease (PD), hypertension, cardiovascular diseases, cancers, and pain. However, few clinically approved CaV3.x blockers are available, and selective pharmacological tools are needed to further unravel the roles of individual CaV3.x subtypes. In this work, through an efficient synthetic route to the marine fungal product pseudellone C, we obtained bisindole alkaloid analogs of pseudellone C with a modified tryptophan moiety and identified two CaV3.2 (2, IC50 = 18.24 µM; 3, IC50 = 6.59 µM) and CaV3.3 (2, IC50 = 7.71 µM; 3, IC50 = 3.81 µM) selective blockers using a FLIPR cell-based assay measuring CaV3.x window currents. Further characterization by whole-cell patch-clamp revealed a preferential block of CaV3.1 activated current (2, IC50 = 5.60 µM; 3, IC50 = 9.91 µM), suggesting their state-dependent block is subtype specific.

scholarly journals Amlodipine induced generalized gingival overgrowth: A clinical case

2021 ◽  
Vol 6 (2) ◽  
pp. 125-127
Author(s):  
Sayani Shome ◽  
Amit De ◽  
Arup Ghosh ◽  
Ankita Saraf
Keyword(s):  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Geriatric Patient ◽  
Clinical Case ◽  
Gingival Tissue ◽  
Channel Blockers ◽  
Unique Case ◽  
Gingival Overgrowth ◽  
Management Protocol ◽  
Gingival Enlargement

Calcium channel blockers (CCB) like Amlodipine, Nifedipine etc are widely used as anti-hypertensive drugs which on chronic intake shows gingival enlargement. It is an iatrogenic response of gingival tissue to these drugs along with other category of medications like antiepileptics and immunosuppressants. A unique case of long standing gingival overgrowth due to prolonged usage of CCB such as Amlodipine in a geriatric patient are portrayed herewith clinical, histopathological attributes and management protocol.

scholarly journals A Rare Case Report of Amlodipine-Induced Gingival Enlargement and Review of Its Pathogenesis

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
Sanjeev Joshi ◽  
Sucheta Bansal
Keyword(s):  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Channel Blocker ◽  
Periodontal Diseases ◽  
Clinical Feature ◽  
Channel Blockers ◽  
Gingival Hyperplasia ◽  
Unwanted Side Effect ◽  
Gingival Enlargement ◽  
Rare Case Report

Gingival enlargement is a common clinical feature of gingival and periodontal diseases. It is an unwanted side effect of certain systemic drugs given for nondental treatment. It is being reported with three main groups of drugs like calcium channel blockers (CCBs), immunosuppressants, and anticonvulsants. Among calcium channel blockers, nifedipine causes gingival hyperplasia in about 10% of patients, whereas the incidence of amlodipine-, a third generation calcium channel blocker, induced gingival hyperplasia is very limited. There are very few reports of amlodipine-induced gingival enlargement at a dose of 5 mg. We report a case of amlodipine-induced gingival enlargement in a 45-year-old hypertensive patient taking amlodipine at a dose of 5 mg.

scholarly journals Cyclosporine A and amlodipine induced gingival overgrowth in a kidney transplant recipient: case presentation with literature review

2019 ◽  
Vol 12 (5) ◽  
pp. e229587 ◽  
Author(s):  
Tarun Nanda ◽  
Baljeet Singh ◽  
Parul Sharma ◽  
Karandeep Singh Arora
Keyword(s):  
Calcium Channel ◽  
Kidney Transplant ◽  
Cyclosporine A ◽  
Calcium Channel Blockers ◽  
Kidney Transplant Recipient ◽  
Kidney Transplant Patient ◽  
Channel Blockers ◽  
Drug Induced ◽  
Gingival Overgrowth ◽  
Gingival Enlargement

Drug-induced gingival overgrowth is a condition caused by side effects of treatment with one of three types of drugs: phenytoin (used in epilepsy treatment), cyclosporine A (used in transplantology after allogenic organ transplants) and calcium channel blockers (used in the treatment of hypertension). Gingival overgrowth leads to inflammation within the gums and periodontium and can amplify the existing periodontal disease leading to tooth loss. Patients who have undergone kidney transplant are given immunosuppressants to prevent transplant rejection and mostly it is accompanied with calcium channel blockers to treat hypertension associated with kidney transplant. This article reports a case of recent gingival enlargement associated with cyclosporine A and amlodipine given to a kidney transplant patient from the past 11 years.

EFFECTIVENESS OF NON-SURGICAL PERIODONTAL THERAPY ON AMLODIPINE INDUCED GINGIVAL ENLARGEMENT: A CASE REPORT

2019 ◽  
Vol 3 (11) ◽  
Author(s):  
Dagar Mona ◽  
Kataria Prerna
Keyword(s):  
Case Report ◽  
Calcium Channel ◽  
Calcium Channel Blockers ◽  
Normal State ◽  
Periodontal Therapy ◽  
Channel Blockers ◽  
Scaling And Root Planing ◽  
Drug Induced ◽  
Gingival Overgrowth ◽  
Gingival Enlargement

Gingival enlargement, [sometimes abbreviated to GO (gingival overgrowth)] is an increase in the size of the gingiva. It is a common feature of gingival disease. Gingival enlargement is a well known side-effect of drugs like anticonvulsants, calcium channel blockers and immunosuppressant. A case of amlodipine induced gingival enlargement was reported and after drug substitution when the patient was treated non-surgically (scaling and root planing), the enlargement subsides to a normal state which suggested the effectiveness of non-surgical periodontal therapy in the treatment of drug induced gingival enlargement. Keywords: Anticonvulsants, Immunosuppressants, Calcium channel blockers, gingival enlargement

Sign in / Sign up

Export Citation Format

Share Document